文献速递骨显像与常规 SPECT肿瘤 PET/CT放射性药物与辐射防护

骨内血管瘤的多模态影像:典型与非典型表现

Imaging intraosseous hemangiomas: Typical and atypical features across modalities.
PubMed 文献 · Semin Nucl Med · 2026-09-03

本文综述骨内血管瘤在X线、CT、MRI及核医学(骨显像、FDG PET/CT、PSMA PET、SSTR PET)中的典型与非典型表现,强调其影像可模拟转移瘤等骨髓替换性病变,并指出核医学摄取变异大且非特异,需结合既往CT/MRI进行判读。

要点

  • 骨内血管瘤CT/MRI典型表现包括垂直骨小梁、斑点征、灯心绒征及T1/T2高信号。
  • 非典型(乏脂)血管瘤可T1低信号且CT上不明显,易与转移瘤混淆。
  • 核医学摄取(骨显像、FDG、PSMA、SSTR)变异大且非特异,应结合CT/MRI判读。

核心结论

  • 骨内血管瘤的核医学表现变异大且常非特异,单独依据放射性摄取判读不可靠,应结合既往CT和MRI。

研究设计与样本

  • 本文为综述,汇总骨内血管瘤在X线、CT、MRI及核医学多种显像中的典型、非典型和侵袭性表现及判读陷阱。

主要发现

  • 富脂血管瘤典型表现包括X线垂直骨小梁、轴位CT斑点征、矢状或冠状CT灯心绒征及T1和T2加权MRI高信号。
  • 非典型乏脂血管瘤可T1低信号且CT上不明显,影像可与转移瘤和其他骨髓替换性病变重叠。
  • 侵袭性血管瘤常以骨膨胀、皮质中断、硬膜外或椎旁延伸、病理性骨折或神经损害为特征。
  • 99mTc骨显像上病灶常不明显,但也可出现摄取减低或增高。
  • FDG PET/CT上血管瘤通常无摄取或轻度摄取,偶见明显摄取不应孤立解读;PSMA和SSTR靶向PET摄取同样不一致。

临床怎么用

  • 判读骨内血管瘤核医学图像时,应结合既往CT和MRI,而非仅评估放射性摄取程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intraosseous hemangiomas are benign vascular lesions within osseous structures, often found incidentally in the spine. Their imaging appearance consists of a variable mixture of fat, vascular channels, and remodeled trabecular bone. Fat-rich lesions typically have characteristic findings, including but not limited to vertically-oriented trabeculae on radiographs, a "polka-dot" pattern on axial computed tomography (CT), a "corduroy" pattern on sagittal or coronal CT, and hyperintensities on both T1- and T2-weighted magnetic resonance imaging (MRI). Conversely, atypical lesions are lipid-poor and may be T1 hypointense and less conspicuous on CT. Imaging appearance may overlap with metastatic disease and other marrow-replacing processes. Aggressive hemangiomas represent an important clinical subset often characterized by osseous expansion, cortical disruption, and epidural or paravertebral extension, pathologic fracture, or neurologic compromise. In current practice, the evaluation of vertebral hemangiomas with nuclear medicine can be challenging due to highly variable and often non-specific radiotracer uptake. On technetium-99m (99mTc) bone scintigraphy, lesions are often inconspicuous, although decreased or increased uptake may occur. On fluorine-18 fluorodeoxyglucose (FDG) PET/CT, hemangiomas are usually non-avid or mildly avid, but occasional marked uptake should not be interpreted in isolation. Uptake on prostate-specific membrane antigen (PSMA)- and somatostatin receptor (SSTR)-targeted PET is similarly inconsistent. Regardless of the radiotracer used, correlation with prior imaging, particularly on CT and MRI, is more reliable than assessing radiotracer avidity alone. This review presents a practical multimodal framework for recognizing typical, atypical, and aggressive intraosseous hemangiomas in adult and pediatric presentations with common nuclear medicine interpretation pitfalls.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bonzell C, Lee J, Santoso MR, et al. Imaging intraosseous hemangiomas: Typical and atypical features across modalities. Semin Nucl Med. 2026. PMID: 42692934. doi:10.1053/j.semnuclmed.2026.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。